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Gait in Elderly With Cerebral Small Vessel Disease
Karlijn F. de Laat, MD; Anouk G.W. van Norden, MD; Rob A.R. Gons, MD;
Lucas J.B. van Oudheusden, MSc; Inge W.M. van Uden, MD; Bastiaan R. Bloem, MD, PhD;
Marcel P. Zwiers, PhD; Frank-Erik de Leeuw, MD, PhD
Background and Purpose—Gait disorders are common in the elderly and are related to loss of functional independence
and death. White matter lesions (WMLs) may be related, but only a minority of individuals with WMLs has gait
disorders. Probably other factors are involved, including location and the independent effect of frequently coinciding
lacunar infarcts, the other aspect of cerebral small vessel disease. The aim of our study was to investigate the effect of
both the severity and location of both WMLs and lacunar infarcts on gait.
Methods—Four hundred thirty-one independently living, nondemented elderly aged between 50 and 85 years with cerebral
small vessel disease were included in this analysis and underwent MRI scanning. The number and location of lacunar
infarcts were rated and WML volume was assessed by manual segmentation with automated delineating of different
regions. Gait was assessed quantitatively with an electronic walkway as well as the semiquantitatively Tinetti and
Timed-Up-and-Go test.
Results—WMLs and lacunar infarcts were both independently associated with most gait parameters with stride length as
the most sensitive parameter related to WMLs. WMLs in the sublobar (basal ganglia/internal capsule) and limbic areas
and lacunar infarcts in the frontal lobe and thalamus were related to a lower velocity.
Conclusions—Cerebral small vessel disease is related to gait disturbances. Because small vessel disease may, in part, be
preventable, it should be regarded as a potentially important target for postponing gait impairment. (Stroke. 2010;41:
1652-1658.)
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Gait disturbances are common in the elderly and areassociated with loss of functional independence, insti-
tutionalization, and death.1 Proper gait is the result of auto-
mated spinal motor programs under supraspinal control. The
integrity of connections between the cortical areas and
between these areas and the spinal cord can be disrupted by
small vessel disease (SVD), including white matter lesions
(WMLs) and lacunar infarcts. WMLs are recognized as a
possible cause of gait impairment,2–7 but not all individuals
with WMLs have gait disturbances.2 It may be that the
severity of WMLs or the frequent coinciding lacunar infarcts
play a role. Remarkably, there was no statistical control for
the presence of lacunar infarcts in most of these studies and
they did not investigate the independent effect of these
lesions on gait.3–6 Moreover, the site of SVD in relation to
gait could be another important factor, but was usually not
taken into account. Only few studies with small sample size
investigated the effect of WML location on gait.8–10
Quantitative gait analysis, providing insight into the dif-
ferent components of gait, has been performed in patients
with extensive SVD with severe gait disorders.2 However,
most studies among independently living elderly with SVD
used semiquantitative clinical rating scales,3,6 a composite
gait score,7 or measured only gait velocity.3,6 Hence, it is not
clear how SVD alters the different parameters of the gait
pattern in the early stages of the disease and which parameter
is a sensitive indicator for underlying SVD.
The aim of our study was therefore to investigate the
individual contribution of WML volume and lacunar infarcts,
overall and by specific location, on different gait parameters
using quantitative gait analysis.
Subjects and Methods
Study Population
The Radboud University Nijmegen Diffusion tensor and MRI Cohort
(RUN DMC) study is a prospective cohort study that was designed
to investigate risk factors and cognitive, motor, and mood conse-
quences of functional and structural brain changes in the elderly with
cerebral SVD.
In subjects with cerebral SVD, symptoms are due to either
complete (lacunar infarcts) or incomplete infarction (WMLs) of
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subcortical structures that might lead to acute symptoms as transient
ischemic attacks or lacunar syndromes or subacute manifestations as
cognitive, motor, and/or mood disturbances.11 Because the onset of
cerebral SVD is often insidious, clinically heterogeneous and with
mild symptoms, it has been suggested that the selection of subjects
with cerebral SVD in clinical studies should be based on the more
consistent brain imaging features.12 Accordingly, in 2006, consecu-
tive patients from the department of neurology between October
2002 and November 2006 were selected for participation.
Inclusion criteria were: (1) age between 50 and 85 years; (2)
cerebral SVD on neuroimaging; and (3) acute (n219) or subacute
(n284) clinical symptoms of SVD as assessed by standardized
structured assessments. Patients who were eligible because of a
lacunar syndrome were included only 6 months after the event to
avoid acute effects on the outcomes.
Exclusion criteria were: (1) dementia; and (2) parkinson(ism)
according to the international diagnostic criteria13–15; (3) life expect-
ancy of 6 months; (4) intracranial space-occupying lesion; (5)
(psychiatric) disease interfering with cognitive testing or follow-up;
(6) recent or current use of acetylcholine–esterase inhibitors, neuro-
leptic agents, L-dopa, or dopa-a(nta)gonists; (7) WML mimics (eg,
multiple sclerosis and irradiation induced gliosis); (8) prominent
visual or hearing impairment; (9) language barrier; and (10) MRI
contraindications or known claustrophobia.
From 1004 invited individuals by letter, 727 were eligible after
contact by phone and 525 agreed to participate. In 22 subjects,
exclusion criteria were found during their visit to our research center,
yielding a response of 71.3% (503 of 705). These 503 individuals
had symptoms of transient ischemic attack or lacunar syndrome
(n219), cognitive disturbances (n245), motor disturbances
(n97), depressive symptoms (n100), or a combination thereof. A
motor disturbance was defined, in accordance with operationaliza-
tion as used in other large-scale studies on cerebral SVD and gait,16
as follows: a reported history of 1 falls during the past year or a
self-reported slowing of gait. All participants signed an informed
consent form. The Medical Review Ethics Committee of region
Arnhem-Nijmegen approved the study.
Measurement of Gait
Quantitative gait analysis was performed with a 5.6-m electronic
portable walkway (GAITRite; MAP/CIR Inc, Havertown, Pa). We
measured velocity (m/s), consisting of the stride length (m; the
distance between the heel points of 2 consecutive footprints of the
same foot) and cadence (number of steps per minute), stride width
(cm; the distance between the midpoint of a footprint to the line of
progression of the opposite foot), double support percentage (per-
centage of the gait cycle time during which both feet are on the
floor), and variability of stride length, stride time, and stride width,
2 times at a self-selected speed. Variability was expressed as
coefficients of variation: SD/mean100%.
Semiquantitative assessment consisted of the modified Tinetti test
with 17 items: 9 for body balance (score 0 to 16) and 8 for gait (score
0 to 12) with a maximum score of 28 as well as the Timed-Up-
and-Go (TUG) test, which was executed three times. Interrater
reliability was calculated in a random sample of 15% with an
intraclass correlation coefficient of 0.99.
MRI Scanning and Processing
Imaging was performed on a 1.5-Tesla scanner (Magnetom Sonata;
Siemens Medical Solutions, Erlangen, Germany). The protocol
included 3-dimensional T1 magnetization-prepared rapid gradient-
echo imaging (time repetition/time echo/time interval 2250/3.68/850
ms; flip angle 15°; voxel size 1.01.01.0 mm) and fluid-attenuated
inversion recovery sequences (time repetition/time echo/time inter-
val 9000/84/2200 ms; voxel size 1.01.25.0 mm, plus an interslice
gap of 1 mm). All scans were performed on the same scanner.
White matter signal hyperintensities on fluid-attenuated inversion
recovery scans, which were not, or only faintly, hypointense on
T1-weighted images, were considered WMLs, except for gliosis
surrounding infarcts. WMLs were manually segmented on the
fluid-attenuated inversion recovery images by 2 trained raters. All
imaging analyses were performed by raters blinded to clinical
information. Also, the WML volume of predefined volumes of
interest, taken from an inversely normalized (parameters taken from
the T1 normalization) Talairach-based atlas17 (WFU Pickatlas, Ver-
sion 2.3), was computed. They included the frontal, parietal, occip-
ital, temporal lobes, and sublobar (basal ganglia, thalamus, internal
and external capsule, insula) and limbic (cingulate gyrus) area, brain
stem, and cerebellum. Lacunar infarcts were defined as areas with a
diameter 2 mm and 15 mm with low signal intensity on T1 and
fluid-attenuated inversion recovery ruling out enlarged perivascular
spaces and infraputaminal pseudolacunes.18 In a random sample of
Table 1. Characteristics of the Study Population
Characteristics N431
Demographic and clinical characteristics
Age at admission, years 63.8 (8.9)
Age at enrollment, years 65.2 (8.9)
Disease duration, years* 1.4 (1.1)
Female, no. 195 (45.2)
Height, m 1.7 (0.1)
Mini Mental State Examination 28.2 (1.6)
Barthel Index 19.7 (0.7)
Neuroimaging characteristics
TBV, mL 1098.9 (119.5)
White matter volume, mL 467.5 (64.9)
WML volume, mL 6.5 (3.2–17.7)
Frontal 2.1 (0.9–6.1)
Parietal 0.2 (0.0–1.1)
Occipital 0.6 (0.3–1.1)
Temporal 0.4 (0.1–1.6)
Sublobar 2.5 (1.2–4.5)
Limbic 0.4 (0.2–1.1)
Infratentorial 0.2 (0.1–0.6)
Lacunar infarcts, no. 132 (30.6)
Frontal 47 (10.9)
Parietal 23 (5.3)
Occipital 14 (3.2)
Temporal 11 (2.6)
Sublobar (basal ganglia/internal capsule) 74 (17.2)
Limbic 0 (0)
Infratentorial 25 (5.8)
Gait characteristics
Gait velocity, m/s 1.3 (0.3)
Stride length, m 1.4 (0.2)
Cadence, steps/min 112.1 (10.8)
Stride width, cm 10.8 (3.1)
Double support percentage 25.8 (4.2)
Stride length variability, % 1.7 (1.2–2.5)
Stride time variability, % 1.6 (1.2–2.3)
Stride width variability, % 17.1 (12.4–24.0)
Tinetti test 28.0 (28.0–28.0)
TUG test, seconds 8.7 (7.7–10.3)
TUG test, no. of steps 12.4 (3.4)
Data represent no. (%), mean (SD) or median (interquartile range).
*Defined as age at enrollmentage at admission.
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10%, interrater variability for WMLs yielded an intraclass correla-
tion coefficient of 0.99; intra- and interrater reliability for lacunar
infarctions a weighted  of 0.80 and 0.88.
Automated segmentation on the T1 images was conducted using
Statistical Parametric Mapping (SPM5; www.fil.ion.ucl.ac.uk/spm/)
to obtain gray and white matter and cerebrospinal fluid maps.19 Total
brain volume (TBV) was calculated as the sum of total gray and
white matter volumes.
Other Measurements
We considered age, sex, height, and TBV as possible confounders.
We used the Mini Mental State Examination score (range 0 to 30) to
assess global cognitive status. Functional independence was assessed
using the Barthel Index (range 0 to 20).
Statistical Analysis
The mean quantitative GAITRite and semiquantitative TUG mea-
sures were calculated as the mean of the 2 and 3 walks. When 1 trial
was missing, the remaining measures were used (n3 for quantita-
tive and n2 for semiquantitative gait assessment).
The relation between SVD and gait was analyzed using 3 different
approaches. First, we used age, sex, height, and TBV adjusted
multiple linear regression to investigate the relation between WML
volume or number of lacunar infarcts and gait. Subsequently, we
adjusted for either the number of lacunar infarcts (with WMLs as
independent variable) or WML volume (with lacunar infarcts as
independent variable). This was also done by location of the WMLs
and presence of lacunar infarcts. In positively skewed distributions,
log transformation was used. Regression coefficients were presented
as standardized  values. Second, a possible independent dose–
effect relation of WMLs and number of lacunar infarcts with gait
velocity was investigated by means of analysis of covariance with
WMLs in quintiles or number of lacunar infarcts in 3 groups and the
previously mentioned covariates. Third, the risk of impaired gait
(velocity 1 m/s20 or TUG test 12 seconds21) by the severity of
WMLs (in quintiles) or the number of lacunar infarcts was assessed
with logistic regression analysis. Because no impaired TUG test was
observed in the first quintile, the first and second quintiles together
were considered as the reference group.
All analyses were performed using SPSS Version 16.0.
Results
Characteristics
All gait variables were available for 488 participants. Fifteen
individuals could not participate because of walking aids
(n4), current levodopa use (n1), drop foot (n1), lower
extremity amputation (n1), joint fusion (n2), severe
arthritis (n1), severe vascular problems of the lower ex-
tremity (n2), or a functional gait disturbance (n3). Terri-
torial infarcts were considered confounders and therefore
individuals with these infarcts were excluded (n56). One
subject had to be excluded because of technical problems
with the calculation of the TBV, yielding a final sample size
of 431 subjects.
Table 1 represents the characteristics of these 431 subjects.
The mean age was 65.5 years with 43% being women.
Eighty-four subjects were classified as having a motor dis-
turbance. Of these 84, none had a mild or severe hemiplegia
(Medical Research Council Scale Grade4). Furthermore, of
all subjects with a history of a transient ischemic attack or
lacunar syndrome, 4 participants were still having a mild
hemiplegia of 1 of their legs at the time of enrollment. All
analyses were repeated excluding these 4 subjects. This did
not markedly change the magnitude of the association. We
therefore present the results for the group as a whole. Of all
the participants, 11.6% had a gait velocity1 m/s and 10.4%
a TUG test 12 seconds.
Severity of SVD and Gait
WMLs and lacunar infarcts were both independently associ-
ated with most of the spatiotemporal gait parameters (Table
2) and borderline significant with variability in stride length
(0.10; P0.055 and 0.10; P0.066). Regarding the
clinical rating scales, there was an association between
WMLs and the number of steps needed during the TUG test
but not with the duration of the test. Lacunar infarcts were
related with both tests (Table 2). In analyses restricted to
subjects without lacunar infarcts, WMLs were only associ-
ated with a shorter stride length (0.13; P0.006) and
not with other parameters or clinical rating scales.
The Figure shows a dose–effect relation among the severity
of WMLs, lacunar infarcts, and gait velocity (P trend0.003).
Those with severe (fifth quintile) WMLs were 4 times more
Table 2. Association Between Cerebral SVD and Gait
Gait Parameters
GAITRite Parameters Clinical Rating Scales
Cerebral SVD
Gait
Velocity, m/s
Stride
Length, m
Cadence,
Steps/min
Stride
Width, cm
DSP,
%
CV Stride
Length,* %
CV Stride
Time,* %
CV Stride
Width,* %
Tinetti
Test
TUG Test,*
Seconds
TUG Test,
No. of Steps
WML volume, mL
Model 1 0.21‡ 0.22‡ 0.08 0.25‡ 0.19‡ 0.15† 0.13† 0.12† 0.23‡ 0.16† 0.18‡
Model 2 0.14† 0.16‡ 0.03 0.20‡ 0.10 0.10 0.06 0.09 0.10 0.08 0.12†
Lacunar infarcts, no.
Model 1 0.20‡ 0.20‡ 0.13† 0.19‡ 0.23‡ 0.14† 0.16† 0.11† 0.32‡ 0.20‡ 0.17‡
Model 2 0.14† 0.13† 0.12† 0.10† 0.19‡ 0.10 0.14† 0.07 0.28‡ 0.17† 0.12†
Data are standardized  values.
Model 1 represents the relation between WML volume in milliliters or no. of lacunar infarcts and gait adjusted for age, sex, height, and TBV; Model 2 is with
additional adjustment for no. of lacunar infarcts or WML volume.
*For skewed variables, the logarithm is presented.
†P0.05.
‡P0.001.
DSP indicates double support percentage; CV, coefficients of variation.
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likely to have an abnormal gait velocity or an abnormal TUG
test than the reference group. Subjects with 2 lacunar
infarcts had an OR of 4.5 (95% CI, 1.7 to 12.0) for impaired
gait velocity and 3.1 (95% CI, 1.1 to 8.7) for an impaired
TUG test (Table 3).
Location of SVD and Gait
Because gait velocity is dependent on stride length and
cadence, we examined these 3 parameters separately. WMLs
in all regions were associated with gait velocity with the
strongest association in the sublobar and limbic regions and
to a lesser extent in the frontal lobe, due to a reduction in
stride length. Lacunar infarcts in the frontal lobe were related
to both a shorter stride length (0.08; P0.042) and
lower step frequency (0.11; P0.025), resulting in a
lower gait velocity. Those subjects with thalamic infarcts
walked slower (0.13; P0.005) due to a shorter stride
length. Cadence was also related with the presence of lacunar
infarcts in the brain stem (0.13; P0.005; Table 4).
Discussion
Both WMLs and lacunar infarcts were independently associ-
ated with several gait parameters. WMLs particularly in the
sublobar (basal ganglia, thalamus, internal and external cap-
sule, insula), limbic area, and frontal lobe seemed to be
related to a lower gait velocity, due to a shorter stride length,
and lacunar infarcts in the thalamus and frontal lobe to a
lower gait velocity, due to, respectively, a shorter stride
length and both a reduced stride length and cadence.
Some methodological issues need to be considered. First,
we report on cross-sectional data, which prevent causal
inference. Furthermore, in the examination of the influence of
the location of SVD, a potential confounder could be the
presence of SVD in other regions related to gait, which are
highly correlated with each other. We tried to overcome this
problem by analyzing the relations in 2 separate models, 1
with and 1 without taking into account the possible confound-
ing effect of SVD in the other regions. As a major advantage
of our study, WML volume was obtained by manual segmen-
Figure. Dose–effect relation of cerebral SVD and gait velocity. Adjusted for age, sex, height, TBV, and number of lacunar infarcts (A) or
WMLs (B; with SEs).
Table 3. Association Between Severity of Cerebral SVD and Impaired Gait
Severity of
Cerebral SVD
Impaired Gait Velocity* Impaired TUG Test†
OR (95% CI) No./Total‡ OR (95% CI) No./Total‡
WML volume in
quintiles (range
in mL)
Firstsecond (0.5–5.1) 1.0 (reference) 5/172 1.0 (reference) 4/172
Third (5.1–8.9) 4.1 (1.3–12.5)§ 12/87 2.7 (0.8–9.8) 8/87
Fourth (8.9–20.6) 2.0 (0.6–6.6) 10/86 2.5 (0.7–8.9) 11/86
Fifth (20.6–139.7) 4.3 (1.3–14.1)§ 23/86 4.4 (1.2–15.8)§ 22/86
Lacunar infarcts
0 1.0 (reference) 23/299 1.0 (reference) 22/299
1 or 2 1.4 (0.6–3.1) 13/93 1.0 (0.4–2.4) 11/93
2 4.5 (1.7–12.0)§ 14/39 3.1 (1.1–8.7)§ 12/39
Adjusted for age, sex, height, TBV, and no. of lacunar infarcts or WMLs.
*Defined as 1 m/s in gait velocity.
†Defined as a TUG test of 12 seconds.
‡No. represents the absolute no. of subjects with an impaired gait velocity or TUG test in that group.
§P0.05.
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tation with automated delineating of different regions. Gait
was also assessed in a quantitative manner as well as with
semiquantitative rating scales, because these tests are fre-
quently used and easy to apply in everyday clinical practice.
Another strong element of our study was the fact that we were
able to investigate the effect of SVD on gait independent of
possible confounders such as TBV and lacunar infarcts (and
WMLs with lacunar infarcts as an independent variable). We
intentionally did not correct for vascular risk factors as
hypertension or diabetes because they were considered part of
the causal chain between SVD and gait. Finally, our study
was large with a high response and with all subjects examined
by only 2 investigators in a single center.
Gait velocity is determined by both the stride length and
cadence and was found to be associated with both aspects of
SVD in our study. No studies discriminated between these 2
components of velocity. We showed that cadence was only
reduced in association with lacunar infarcts. In analyses
restricted to subjects without lacunar infarcts, WML volume
was significantly related with stride length but not with
velocity or other parameters. We therefore suggest that stride
length is a more sensitive indicator for (subclinical) SVD than
velocity. This is also reflected by more steps needed during
the TUG test in subjects with a higher WML volume, but
without a significant effect on the duration of the test. The
same is observed in other gait disorders such as Parkinson
disease and normal pressure hydrocephalus.22 In conclusion,
these results suggest that measuring stride length instead of
velocity could lead to early detection of gait abnormalities in
SVD.
Apart from the lower velocity, due to smaller steps and in
the presence of lacunar infarcts also due to a lower step
Table 4. Association Between Location of Cerebral SVD and Gait
Gait Parameters
Cerebral SVD Gait Velocity, m/s Stride Length, m Cadence, Steps/min
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
Frontal lobe
WML volume, mL 0.17† 0.06 0.19† 0.09 0.04 0.05
Lacunar infarcts 0.11* 0.11* 0.09* 0.08* 0.11* 0.11*
Parietal lobe
WML volume, mL 0.17† 0.06 0.19† 0.02 0.04 0.09
Lacunar infarcts 0.01 0.04 0.04 0.07 0.03 0.01
Occipital lobe
WML volume, mL 0.12* 0.02 0.12* 0.04 0.08 0.05
Lacunar infarcts 0.05 0.03 0.05 0.03 0.03 0.02
Temporal lobe
WML volume, mL 0.16* 0.14 0.18† 0.06 0.04 0.18
Lacunar infarcts 0.02 0.04 0.02 0.01 0.07 0.08
Sublobar areas
WML volume, mL 0.19† 0.14 0.18† 0.09 0.10* 0.13
Lacunar infarcts 0.09* 0.06 0.10* 0.08 0.04 0.01
Limbic areas
WML volume, mL 0.20† 0.13 0.22† 0.14 0.08 0.06
Lacunar infarcts      
Infratentorial
WML volume, mL 0.18† 0.03 0.19† 0.03 0.07 0.05
Lacunar infarcts 0.05 0.02 0.01 0.01 0.11* 0.10*
Brain stem
WML volume, mL 0.15* 0.01 0.16† 0.00 0.06 0.03
Lacunar infarcts 0.08 0.06 0.04 0.02 0.14* 0.13*
Cerebellum
WML volume, mL 0.21† 0.11 0.22† .14 0.08 0.06
Lacunar infarcts 0.03 0.01 0.02 .00 0.05 0.04
Data are standardized  values.
Model 1 represents the independent association between WML volume in milliliters, presence of lacunar infarcts,
and gait adjusted for age, sex, height, and TBV; Model 2 is with additional adjustment for WMLs and presence of
lacunar infarcts in the other regions.
*P0.05.
†P0.001.
1656 Stroke August 2010
 at Radboud Universiteit Nijmegen on July 12, 2012http://stroke.ahajournals.org/Downloaded from 
frequency, we found that gait in subjects with more severe
SVD was characterized by a broader base, more shuffling,
reflected by increased double support percentage, and with a
higher variability in stride time and trend to a higher stride
length variability. Rosano et al did not detect an effect of
SVD on stride width in contrast to our finding of a clear
relation with both aspects of SVD.4 The association of
lacunar infarcts with double support percentage is also a
novel finding. Gait variability, which is suggested to be more
sensitive to fall risk than other gait parameters,23 has not been
extensively studied in the early stages of SVD. Although the
effect of WML on overall gait variability was recently
reported,7 our data provide insight into the different compo-
nents because we showed an association between variability
in stride time and to a lesser extent in stride length and SVD.
Because the presence of 3 lacunar infarcts was signifi-
cantly associated with gait velocity, our findings suggested a
threshold rather than a dose–effect. However, those with 4
lacunar infarcts were limited and could therefore not be
investigated separately. In contrast, the relation between
WML and gait suggested a dose-dependent effect. A similar
finding was reported by 2 other studies.3,7 One study showed
a threshold effect, but the median WML volume in this study
was lower than in our study.6 They found a significant lower
gait velocity with WML volume 5 to 10 mL like we did.
Hence, it seems that gait impairment only occurs when
WMLs are moderate or (in the combination) with more
lacunar infarcts.
The exact cerebral networks impaired in gait disorders due
to SVD have not been identified yet. In previous studies in
subjects with gait impairment and extensive SVD, the frontal
basal ganglia–thalamocortical circuit was considered to be
involved.2 Our findings support this hypothesis, even during
the early stages of SVD because we showed that lacunar
infarcts in the frontal lobe were related to a lower gait
velocity. Furthermore, we found WMLs in the sublobar
region and thalamic infarcts to be related to gait velocity.
Rosano et al also suggested that lacunar infarcts in the basal
ganglia were related to gait velocity because most of the
infarcts in their population were located in the basal ganglia,
but their sample size was too small for subanalyses.4 A
remarkable finding in our study was the relevance of WMLs
in the limbic area for gait velocity. This is in accordance with
a functional MRI study that showed, except for activation of
the dorsal premotor cortex and supplementary motor area,
also activation of the cingulated motor area and the parahip-
pocampal gyri.24 These latter 2 areas are part of the limbic
area and believed to be required for spatial navigation. At last,
we found that lacunar infarcts in the brain stem were
associated with a lower cadence. This suggests that cadence is
regulated, among others, by regions in the brain stem (and
cerebellum) such as the mesencephalic locomotor regions.
One other study also demonstrated that persons with WMLs
in the brain stem walked more slowly.10 Our findings support
the notion that gait relies on widespread cerebral networks
that are vulnerable to the disruption by SVD resulting in
impaired gait. Further studies, for example with the aid of
diffusion tensor imaging, may be useful to investigate the
disruption of these networks by cerebral SVD more precisely.
In conclusion, cerebral SVD contributes to disturbances in
gait even at a preclinical level that currently cannot be
identified properly with standard semiquantitative clinical
tests. Stride length may be a useful measure for the early
detection of gait abnormalities due to SVD. Follow-up studies
are needed to study possible gait deterioration in those
patients. A clinical rule of thumb could be that gait distur-
bances should only be attributed to SVD in patients with
moderate or severe WMLs and/or with the presence of 3
lacunar infarcts, especially at specific locations. This pro-
vides an explanation why only some patients with SVD have
gait disturbances. Because cerebral SVD may, in part, be
preventable, it should be regarded as a potentially therapeutic
target for postponing gait impairment.
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